Paper: High Dose Melphalan with Autologous Stem Cell Transplantation Overcomes Poor Prognosis of Primary Amyloidosis
Links shared publicly online about this topic.
- 702total visits
Paper: High Dose Melphalan with Autologous Stem Cell Transplantation Overcomes Poor Prognosis of Primary Amyloidosis
Paper: High Dose Melphalan with Autologous Stem Cell Transplantation Overcomes Poor Prognosis of Primary Amyloidosis
View full resource at ash.confex.com
Tags: Amyloidosis, Stem Cell, Transplantation
Most Recently Shared on November 25, 2010 at 4:14 am By:
MD Anderson data: Outcome of patients with primary systemic AL amyloidosis was durable with stem cell transplant (http://bit.ly/fDCBm6).
Advertisement
